Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Seer Inc Cl A (SEER)

Seer Inc Cl A (SEER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 112,842
  • Shares Outstanding, K 56,421
  • Annual Sales, $ 16,580 K
  • Annual Income, $ -73,600 K
  • EBIT $ -78 M
  • EBITDA $ -71 M
  • 60-Month Beta 1.59
  • Price/Sales 6.98
  • Price/Cash Flow N/A
  • Price/Book 0.44

Options Overview Details

View History
  • Implied Volatility 609.31% (-76.90%)
  • Historical Volatility 46.54%
  • IV Percentile 98%
  • IV Rank 87.86%
  • IV High 686.21% on 04/15/26
  • IV Low 52.65% on 06/09/25
  • Expected Move (DTE 25) 0.04 (2.13%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 47
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 903
  • Open Int (30-Day) 848
  • Expected Range 1.96 to 2.04

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-0.34
  • Growth Rate Est. (year over year) +293,923.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.65 +21.21%
on 03/31/26
2.05 -2.44%
on 04/17/26
+0.22 (+12.36%)
since 03/17/26
3-Month
1.65 +21.21%
on 03/31/26
2.20 -9.09%
on 02/20/26
+0.11 (+5.82%)
since 01/16/26
52-Week
1.65 +21.21%
on 03/31/26
2.41 -17.01%
on 10/24/25
+0.03 (+1.52%)
since 04/17/25

Most Recent Stories

More News
Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group

REDWOOD CITY, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today confirmed...

SEER : 2.00 (-2.44%)
The Radoff-JEC Group Submits Non-Binding Proposal to Acquire Seer, Inc.

Proposal Provides Stockholders $2.25 per Share in Cash, a 33% Premium to the Most Recent Closing Price, as Well as Potential Additional Value from the Sale of Seer’s Assets via a Contingent Value Right...

SEER : 2.00 (-2.44%)
Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples

REDWOOD CITY, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Proteograph ®...

SEER : 2.00 (-2.44%)
Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries

REDWOOD CITY, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leader in deep, unbiased proteomic insights, today announced that the Patent Trial and Appeal Board (“PTAB”)...

SEER : 2.00 (-2.44%)
The Radoff-JEC Group Sends Open Letter to Seer, Inc. Unconflicted Independent Directors Meeta Gulyani and Nicolas Roelofs

Raises Concerns About the Board’s Continued Deference to Chair and CEO Dr. Omid Farokhzad in Light of His Track Record of Value Destruction Highlights Recently Filed...

SEER : 2.00 (-2.44%)
Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets

REDWOOD CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Board of Directors unanimously...

SEER : 2.00 (-2.44%)
Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook

REDWOOD CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the fourth...

SEER : 2.00 (-2.44%)
The Radoff-JEC Group Issues Open Letter to Seer Inc.’s Board of Directors Regarding the Immediate Need for Significant Change

Highlights Seer’s Abysmal Operating Results and Severe Undervaluation Under the Leadership of Co-Founder, Board Chair and CEO Dr. Omid Farokhzad

SEER : 2.00 (-2.44%)
Leading Scientists Demonstrate How Seer’s Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026

REDWOOD CITY, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced its participation in the...

SEER : 2.00 (-2.44%)
Seer to Participate in the TD Cowen 46th Annual Health Care Conference

REDWOOD CITY, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be participating...

SEER : 2.00 (-2.44%)

Business Summary

Seer Inc. is a life sciences company. It engages in developing Proteograph(TM), which is an integrated solution consisting of consumables, automation instrumentation and proprietary software. Seer Inc. is based in REDWOOD CITY, Calif.

See More

Key Turning Points

3rd Resistance Point 2.12
2nd Resistance Point 2.09
1st Resistance Point 2.04
Last Price 2.00
1st Support Level 1.96
2nd Support Level 1.93
3rd Support Level 1.88

See More

52-Week High 2.41
Fibonacci 61.8% 2.12
Fibonacci 50% 2.03
Last Price 2.00
Fibonacci 38.2% 1.94
52-Week Low 1.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.